A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-1261 in participants with advanced or metastatic prostate cancer. It's also to identify a recommended dose(s) and regimen for GDC-1261 for subsequent studies.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent ma dobry stan ogólny (zdolny do lekkich czynności)
- •Oczekiwana długość życia co najmniej 3 miesiące
- •Potwierdzony diagnozą rak gruczołu krokowego
- •Nowotwór się rozprzestrzenił do innych części ciała
- •Pacjent otrzymuje leczenie hormonalne prostaty
- •Dobra funkcja nerek, wątroby i serca
✗ Disqualifies
- •Pacjent otrzymywał inną chemioterapię w ostatnich 14 dniach
- •Przerzuty w mózgu bez leczenia
- •Silny ból, który nie jest kontrolowany
- •Inne nowotwory w ciągu ostatnich 5 lat
- •Aktywna infekcja wymagająca antybiotyków
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 9, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (4)
Honor Health Research Institute
Scottsdale, United States
Sarah Cannon Research Institute
Nashville, United States
St Vincent's Hospital Sydney
Darlinghurst, Australia
Austin Hospital
Heidelberg, Australia
Trial contact
Reference Study ID Number: GO46445 https://forpatients.roche.com/ No attachments to email below.
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.